BlackRock Institutional Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $50.6M | Buy |
798,238
+38,208
| +5% | +$2.42M | 0.01% | 1344 |
|
|
2016
Q3 | $48.4M | Sell |
760,030
-40,367
| -5% | -$2.57M | 0.01% | 1322 |
|
|
2016
Q2 | $59.6M | Buy |
800,397
+41,306
| +5% | +$3.07M | 0.01% | 1131 |
|
|
2016
Q1 | $50.7M | Buy |
759,091
+165
| +0% | +$11K | 0.01% | 1209 |
|
|
2015
Q4 | $51.3M | Sell |
758,926
-2,004
| -0.3% | -$136K | 0.01% | 1226 |
|
|
2015
Q3 | $40.7M | Sell |
760,930
-68,369
| -8% | -$3.65M | 0.01% | 1352 |
|
|
2015
Q2 | $52.2M | Sell |
829,299
-86,165
| -9% | -$5.42M | 0.01% | 1271 |
|
|
2015
Q1 | $44M | Sell |
915,464
-15,337
| -2% | -$738K | 0.01% | 1396 |
|
|
2014
Q4 | $30.9M | Buy |
930,801
+54,205
| +6% | +$1.8M | ﹤0.01% | 1622 |
|
|
2014
Q3 | $25.7M | Sell |
876,596
-74,126
| -8% | -$2.17M | ﹤0.01% | 1724 |
|
|
2014
Q2 | $36.9M | Buy |
950,722
+34,951
| +4% | +$1.36M | 0.01% | 1535 |
|
|
2014
Q1 | $38.4M | Buy |
915,771
+37,151
| +4% | +$1.56M | 0.01% | 1489 |
|
|
2013
Q4 | $28.8M | Sell |
878,620
-38,847
| -4% | -$1.27M | 0.01% | 1665 |
|
|
2013
Q3 | $24.8M | Sell |
917,467
-159,547
| -15% | -$4.31M | ﹤0.01% | 1701 |
|
|
2013
Q2 | $25.1M | Buy |
+1,077,014
| New | +$25.1M | 0.01% | 1630 |
|